SP Scientific Announces Summer 2014 Lyophilization Webinars
The LyoLearn programme of free educational webinars, delivered by industry experts, are devoted to lyophilization, freeze-drying and related topics. Attendees to the live sessions are encouraged to ask questions of the presenter and get their answers in real time.
Common Misconceptions in Freeze-Drying (II) is a webinar presentation, due to air on 26 July 2014, which addresses some common misconceptions in freeze-drying (lyophilization) relating to formulations, process cycles, equipment and scale-up. The presentation follows on from Common Misconceptions in Freeze-Drying (I), which discussed basics of the product, process and equipment. In this presentation, Kevin Ward of BioPharma Technology Ltd will challenge some of the myths and misunderstandings relating to the measurement of shelf and product temperatures, the use of some PAT tools and the scalability of parameters from the lab to full-scale manufacturing.
LyoLearn webinars follow a 45-minute format for the presentations with a Q&A session immediately afterwards. To learn more about or register for any of SP Scientific's 2014 programme of informative webinars please visit www.spscientific.com/Webinars
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.